NovaBridge Biosciences ADR (NBP) Unusual Options Activity Today

Checking NBP unusual options activity helps you spot when traders are making outsized bets on NovaBridge Biosciences ADR before the broader market catches on. NovaBridge Biosciences ADR's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor NBP unusual options activity today and surface the prints that deserve a second look.

Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching NBP unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking NBP unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and NBP unusual options flow data becomes especially valuable around earnings, product launches, and macro events.

NovaBridge Biosciences, a biotech company, focuses on the development of immuno-oncology agents for the treatment of cancer in the United States. The company is developing givastomig, a bispecific antibody, which is in Phase 1b clinical trial for the treatment of gastric cancer; uliledlimab, a CD73 neutralizing antibody; and ragistomig, a bispecific antibody, which is in phase 1 clinical trial for the treatment of solid tumors. It has a strategic licensing agreement with Ferring International Center SA to research, develop, make, have made, import, use, sell, and offer to sell FE301, an interleukin-6 inhibitor.

The company also has collaborations with Bristol Myers Squibb for the development of givastomig; ABL Bio, Inc. for the development of givastomig and ragistomig; and TJ Bio for the development of uliledlimab. The company was formerly known as I-Mab and change its name to NovaBridge Biosciences in October 2025. NovaBridge Biosciences was founded in 2014 and is headquartered in Rockville, Maryland.

Catalysts rarely arrive without a footprint, and NBP unusual options activity is often where that footprint shows up first. Our scanner tracks NovaBridge Biosciences ADR's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at NBP unusual options volume on the call side or chasing put sweeps, NovaBridge Biosciences ADR's unusual options flow today is one click away, so put it on your radar before the headlines hit.